Meta Platforms
META
Taiwan Semiconductor
TSM
Amazon
AMZN
Apple
AAPL
NVIDIA
NVDA
US Stock MarketDetailed Quotes
YMAB Y-mAbs Therapeutics
- 10.570
- -1.220-10.35%
Close Dec 3 16:00 ET
473.42MMarket Cap-19574P/E (TTM)
11.860High10.550Low252.33KVolume11.520Open11.790Pre Close2.75MTurnover0.93%Turnover RatioLossP/E (Static)44.79MShares20.90052wk High5.12P/B286.18MFloat Cap6.09052wk Low--Dividend TTM27.07MShs Float55.215Historical High--Div YieldTTM11.11%Amplitude2.700Historical Low10.901Avg Price1Lot Size
About Y-mAbs Therapeutics Company
Y-mAbs Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on the development and commercialization of antibody based therapeutic products for the treatment of cancer. Its services include discovery, protein engineering, clinical and regulatory. Y-mAbs Therapeutics was founded by Thomas Gad in April 2015 and is headquartered in New York, NY.
Company Profile
SymbolYMAB
Company NameY-mAbs Therapeutics
Listing DateSep 21, 2018
Issue Price16.00
Founded2015
CEOMr. Michael Rossi
MarketNASDAQ
Employees100
Fiscal Year Ends12-31
Address230 Park Avenue,Suite 3350
CityNew York
ProvinceNew York
CountryUnited States of America
Zip Code10169-0005
Phone1-646-885-8505
Websitehttp://www.ymabs.com
Company Executives
- Name
- Position
- Salary
- Michael Rossi
- Director, President and Chief Executive Officer
- 3.11M
- Thomas Gad
- Vice Chairman of the Board and Chief Business Officer
- 2.45M
- Sue Smith
- Senior Vice President and Chief Commercial Officer
- 887.28K
- Joris Wiel Jan Wilms
- Senior Vice President and Chief Operating Officer
- --
- Dr. Torben Lund-Hansen, PhD
- Senior Vice President and Chief Technical Officer
- --
- Dr. Steen Lisby
- Senior Vice President and Chief Scientific Officer
- --
- Vignesh Rajah
- Senior Vice President and Chief Medical Officer
- --
- Peter P. Pfreundschuh
- Chief Financial Officer and Treasurer
- --
- Dr. James I. Healy, M.D.,PhD
- Chairman of the Board
- 184.31K
- Dr. Mary A. Tagliaferri, M.D.
- Director
- --
- Dr. Ashutosh Tyagi, M.D.
- Independent Director
- 158.06K
- David N. Gill
- Independent Director
- 180.56K
- Johan Wedell-Wedellsborg
- Independent Director
- 158.06K
- Laura J. Hamill
- Independent Director
- 168.06K